Thermo Fisher Rapid Environmental COVID-19 Test Could Be Key To Keeping Workplaces, Schools Safe

The company’s Renvo Rapid PCR Test can tell users if the COVID-19 virus has been detected in the environment in schools and businesses. It could be a critical in managing the pandemic.

Thermo Fisher's Renvo Rapid PCR Test can test for the SARS-CoV-2 virus in surrounding air give and results in 30 minutes
Thermo Fisher's Renvo Rapid PCR Test can test for the SARS-CoV-2 virus in surrounding air give and results in 30 minutes • Source: Thermo Fisher

Thermo Fisher has begun marketing the Renvo Rapid PCR Test that is able to analyze air in the surrounding environment and help detect the SARS-CoV-2 virus within 30 minutes. While not considered a diagnostic test, it can help spot potential outbreaks in workplaces and schools before they happen.

On 7 February the Massachusetts-based company announced that it has started selling the Renvo Rapid PCR Test environmental surveillance test for communal locations such as schools, businesses and health care...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Salvia Bioelectronics Secures $60M In Series B To Advance Chronic Migraine Implant, Eyes US Trials

 
• By 

Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

German Bionic Launches ‘Strongest Exoskeleton To Date’

 

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.

More from Medtech Insight

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

Commission’s Flora Giorgio Says Simplification And Safety Are Key In Evolving EU Regs

 

Predictability, proportionality, stability, harmonization and simplification offer the right way forward to address the challenging unintended effects of the EU medical device regulations, the European Commission’s head of devices tells the EU’s largest annual medtech conference.